Year: 2011
Type: article
Abstract: A class of immune suppressor cells termed myeloid-derived suppressor cells (MDSC) is known to be elevated in many solid tumor settings.MDSC are a heterogenous population of early myeloid cells that expand from the bone marrow during tumor progression and have the ability to inhibit both innate and adaptive immunity.Previous work from our laboratory and others indicated that patients with cancer exhibited reduced activation of signaling pathways when stimulated with Type I and II IFN as compared to normal donors.This reduced immune response could be a barrier to successful clinical outcomes, since ability to respond to IFN is known to be important for anti-tumor immunity and efficacy of immune-based therapies.We hypothesized that MDSC could inhibit an immune response to the growing tumor by reducing the ability of immune cells to respond to IFN stimulation.C26 tumor-bearing mice had significantly elevated levels of GR1 + /CD11b + MDSC as compared to control mice, and splenocytes from these mice exhibited reduced phosphorylation of STAT1 in response to Type I and II IFN.Depletion of MDSC in C26 bearing mice restored splenocyte IFN responsiveness.Spleens from C26 tumor-bearing animals displayed elevated levels of iNOS and nitric oxide (NO), which was associated with increased levels of nitration on STAT1.In vitro treatment of splenocytes with a nitric oxide donor led to a decreased STAT1 IFN response.Finally, splenocytes from tumor-bearing iNOS knockout mice iii exhibited a significantly elevated IFN-response as compared to WT tumor-bearing mice.This demonstrated a novel mechanism of MDSC inhibition and created a direct link between increased nitric oxide and reduced IFN responsiveness.We further investigated an association between pro-inflammatory cytokines, subsets of MDSC, and reduced IFN responsiveness in patients with GI cancer.Plasma IL-6 was correlated with CD33 + HLADR -CD15 + MDSC, while IL-10 correlated with CD33 + HLADR -CD15 -MDSC.The percentage of multiple MDSC subsets were inversely correlated with IFN-α-induced STAT1 phosphorylation in CD4 + T cells, while co-culture with in vitro generated MDSC led to reduced IFN-α-responsiveness in both PBMC and the CD4 + T cells from normal donors.These data support our findings that MDSC reduce IFN responsiveness and demonstrate that this also occurs in patients with cancer.We also hypothesized that psychological stress could lead to changes in factors that modulate MDSC.It was discovered that patients with high cancer-specific stress had significantly elevated salivary cortisol and IL-1R levels.Interestingly, significantly increased MDSC levels were observed in patients with lower cancer-specific stress.Additional long-term stress analyses of the number of stressful events that affected these patients revealed that patients with more stress overall trended toward elevations in MDSC.This study indicated the existence of a complex relationship between stress and immune function in breast cancer patients.iv Taken together, these data demonstrate a novel mechanism of MDSC action and provide evidence that environmental factors, such as psychological stress, can lead to alterations in MDSC in patients with cancer.v For my family.vi Acknowledgments I would first like to thank my advisor, Dr. William Carson, for accepting me into his lab mid-way through my graduate school career.Thank you for taking a chance, and hopefully I have proven to be a worthy student.You gave me the opportunity to continue and jump into a new area of science, and your lab quickly became a new home for me.I would also like to thank Dr. Greg Lesinski for being available for daily consultation and guiding my development.You pushed me to be a better scientist and look at things from many different angles.I would next like to acknowledge all of the members of the Carson Lab, past and present for their tireless support, and for reminding me that research can actually be fun.Thanks for being there all of the times we had something to celebrate, and especially for being there when the hours were long and the work was hard.To Cristina, you were my best partner in crime and my faithful co-worker no matter what crazy things I asked you to help me with.Thank you to Valerie as well, the three of us together was always a dangerous combination.I would like to thank all of those along the way who have taught me the lessons I learned in graduate school.Although some lessons were good, others were hard, but each experience has created a better scientist and person than the one who started this process six years ago.vii I also am very grateful for the assistance of my committee, Brian Kaspar, Cheryl London, and Tatiana Oberyszyn.They have been a constant source of advice and have been supportive of my goals and projects.Thank you for pushing me to achieve more and put the extra effort into becoming a productive scientist.I finally thank my family, for unrelenting support of this process.Despite the long journey, you have always supported my goals and listened to whatever new topic I was excited about, whether you understood or not.Thank you to my parents, who had faith in me always.Last of all, I would like to thank my husband.Kevin, you went through this process yourself and never complained along the way.Thank you for your patience and your calm presence in the storm of my ever-hectic life.viii
Author: Bethany L. Mundy-Bosse
Institution: The Ohio State University
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: G1229672300, DEVELOPMENT OF NOVEL CORRELATIVE STUDIES FOR A PHASE I, Innate Immunity: Elucidation and Modulation for Cancer Therapy, SOCS proteins as inhibitors of immune surveillance in the melanoma microenvironme, G2390858261, A program of immune-based treatments for cancer, Psychological intervention for women with breast cancer, G5291974308, Biobehavioral responses to cancer, Cancer Center Support Grant
OpenAlex ID: W2258930888
